MoneyWorks4Me

The sales declined to Rs. 11603.30 millions for the June 2022 quarter as compared to Rs. 12696.90 millions during the corresponding quarter last year.The Company to register a -62.40%  fall in the net profit for the quarter ended June 2022.The Operating Profit of the company witnessed a decrease to 1272.50 millions from 2787.10 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202206 202106 % Var 202206 202106 % Var 202203 202103 % Var
Sales 11603.30 12696.90 -8.61 11603.30 12696.90 -8.61 49966.00 50514.40 -1.09
Other Income 6.20 41.60 -85.10 6.20 41.60 -85.10 499.80 835.20 -40.16
PBIDT 1272.50 2787.10 -54.34 1272.50 2787.10 -54.34 11044.30 15819.70 -30.19
Interest 87.00 20.30 328.57 87.00 20.30 328.57 166.70 127.70 30.54
PBDT 1185.50 2766.80 -57.15 1185.50 2766.80 -57.15 10877.60 15692.00 -30.68
Depreciation 460.90 434.90 5.98 460.90 434.90 5.98 1793.10 1526.00 17.50
PBT 724.60 2331.90 -68.93 724.60 2331.90 -68.93 9084.50 14166.00 -35.87
TAX 0.00 405.00 0.00 0.00 405.00 0.00 1144.50 2412.10 -52.55
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 724.60 1926.90 -62.40 724.60 1926.90 -62.40 7940.00 11753.90 -32.45
Equity 393.10 393.10 0.00 393.10 393.10 0.00 393.10 393.10 0.00
PBIDTM(%) 10.97 21.95 -50.04 10.97 21.95 -50.04 22.10 31.32 -29.42

Alembic Pharma Share Price

814.00 -9.50 (-1.15%)
28-Aug-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1920.10
Dr. Reddys Labs. 1177.80
Cipla 1418.00
Lupin 2175.00
Zydus Lifesciences 1187.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: